Skip to content

Philip Tagari

  • MA
  • Executive Director Research
  • Amgen Inc
  • 20PublicationsNumber of items in Philip's My Publications folder on Mendeley.
  • 2Followers


Over 25 years of research experience in the areas of neurobiology, hematology/oncology, metabolic disease, immunology & inflammation, cell and molecular biology, peptide chemistry, analytical chemistry & biochemistry, structural biology, pharmacokinetics, safety pharmacology, laboratory automation and information technologies, leading to several important experimental and marketed therapies and over 65 peer-reviewed publications. Strong executive experience including: multi-facility management (>100 FTE, $10M budget); pipeline review; product & technology licensing; merger/acquisition and venture

Recent publications

  • Discovery of novel hydroxy-thiazoles as HIF-alpha prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluation.

    • Tegley C
    • Viswanadhan V
    • Biswas K
    • et al.
  • Effects of COX-2 Inhibitors on Aortic Prostacyclin Production in Cholesterol-fed Rabbits

    • Wong, E, Huang JQ, Tagari P R

Professional experience

Executive Director Research

Amgen, Inc.

August 1998 - Present

Research Fellow

Merck & Co

December 1987 - August 1998(11 years)



Gonvile & Caius College, Cambridge UK

September 1976 - June 1979(3 years)

Followers (2)

Following (1)